Literature DB >> 28655017

Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013.

Limin Wang1, Pei Gao2, Mei Zhang1, Zhengjing Huang1, Dudan Zhang2, Qian Deng1, Yichong Li1, Zhenping Zhao1, Xueying Qin2, Danyao Jin2, Maigeng Zhou1, Xun Tang2, Yonghua Hu2, Linhong Wang1.   

Abstract

Importance: Previous studies have shown increasing prevalence of diabetes in China, which now has the world's largest diabetes epidemic.
Objectives: To estimate the recent prevalence and to investigate the ethnic variation of diabetes and prediabetes in the Chinese adult population. Design, Setting, and Participants: A nationally representative cross-sectional survey in 2013 in mainland China, which consisted of 170 287 participants. Exposures: Fasting plasma glucose and hemoglobin A1c levels were measured for all participants. A 2-hour oral glucose tolerance test was conducted for all participants without diagnosed diabetes. Main Outcomes and Measures: Primary outcomes were total diabetes and prediabetes defined according to the 2010 American Diabetes Association criteria. Awareness and treatment were also evaluated. Hemoglobin A1c concentration of less than 7.0% among treated diabetes patients was considered adequate glycemic control. Minority ethnic groups in China with at least 1000 participants (Tibetan, Zhuang, Manchu, Uyghur, and Muslim) were compared with Han participants.
Results: Among the Chinese adult population, the estimated standardized prevalence of total diagnosed and undiagnosed diabetes was 10.9% (95% CI, 10.4%-11.5%); that of diagnosed diabetes, 4.0% (95% CI, 3.6%-4.3%); and that of prediabetes, 35.7% (95% CI, 34.1%-37.4%). Among persons with diabetes, 36.5% (95% CI, 34.3%-38.6%) were aware of their diagnosis and 32.2% (95% CI, 30.1%-34.2%) were treated; 49.2% (95% CI, 46.9%-51.5%) of patients treated had adequate glycemic control. Tibetan and Muslim Chinese had significantly lower crude prevalence of diabetes than Han participants (14.7% [95% CI, 14.6%-14.9%] for Han, 4.3% [95% CI, 3.5%-5.0%] for Tibetan, and 10.6% [95% CI, 9.3%-11.9%] for Muslim; P < .001 for Tibetan and Muslim compared with Han). In the multivariable logistic models, the adjusted odds ratios compared with Han participants were 0.42 (95% CI, 0.35-0.50) for diabetes and 0.77 (95% CI, 0.71-0.84) for prediabetes for Tibetan Chinese and 0.73 (95% CI, 0.63-0.85) for diabetes and 0.78 (95% CI, 0.71-0.86) for prediabetes in Muslim Chinese. Conclusions and Relevance: Among adults in China, the estimated overall prevalence of diabetes was 10.9%, and that for prediabetes was 35.7%. Differences from previous estimates for 2010 may be due to an alternate method of measuring hemoglobin A1c.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28655017      PMCID: PMC5815077          DOI: 10.1001/jama.2017.7596

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  21 in total

1.  Prevalence of diabetes among men and women in China.

Authors:  Wenying Yang; Juming Lu; Jianping Weng; Weiping Jia; Linong Ji; Jianzhong Xiao; Zhongyan Shan; Jie Liu; Haoming Tian; Qiuhe Ji; Dalong Zhu; Jiapu Ge; Lixiang Lin; Li Chen; Xiaohui Guo; Zhigang Zhao; Qiang Li; Zhiguang Zhou; Guangliang Shan; Jiang He
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

2.  Ethnic and environmental differences in various markers of dietary intake and blood pressure among Chinese Han and three other minority peoples of China: results from the WHO Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study.

Authors:  L Liu; L Liu; Y Ding; Z Huang; B He; S Sun; G Zhao; H Zhang; T Miki; S Mizushima; K Ikeda; Y Nara; Y Yamori
Journal:  Hypertens Res       Date:  2001-05       Impact factor: 3.872

3.  Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.

Authors:  X R Pan; W Y Yang; G W Li; J Liu
Journal:  Diabetes Care       Date:  1997-11       Impact factor: 19.112

4.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Authors:  N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh
Journal:  Lancet       Date:  2010-06-26       Impact factor: 202.731

5.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012.

Authors:  Andy Menke; Sarah Casagrande; Linda Geiss; Catherine C Cowie
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

6.  Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Authors:  Alexander Thompson; Emanuele Di Angelantonio; Pei Gao; Nadeem Sarwar; Sreenivasa Rao Kondapally Seshasai; Stephen Kaptoge; Peter H Whincup; Kenneth J Mukamal; Richard F Gillum; Ingar Holme; Inger Njølstad; Astrid Fletcher; Peter Nilsson; Sarah Lewington; Rory Collins; Vilmundur Gudnason; Simon G Thompson; Naveed Sattar; Elizabeth Selvin; Frank B Hu; John Danesh
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

7.  Type 2 diabetes in Xinjiang Uygur autonomous region, China.

Authors:  Yi-Ning Yang; Xiang Xie; Yi-Tong Ma; Xiao-Mei Li; Zhen-Yan Fu; Xiang Ma; Ding Huang; Bang-Dang Chen; Fen Liu; Ying Huang; Cheng Liu; Ying-Ying Zheng; Gulinaer Baituola; Zi-Xiang Yu; You Chen
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

8.  Geographical variation in diabetes prevalence and detection in china: multilevel spatial analysis of 98,058 adults.

Authors:  Maigeng Zhou; Thomas Astell-Burt; Yufang Bi; Xiaoqi Feng; Yong Jiang; Yichong Li; Andrew Page; Limin Wang; Yu Xu; Linhong Wang; Wenhua Zhao; Guang Ning
Journal:  Diabetes Care       Date:  2014-10-28       Impact factor: 19.112

9.  An integrated national mortality surveillance system for death registration and mortality surveillance, China.

Authors:  Shiwei Liu; Xiaoling Wu; Alan D Lopez; Lijun Wang; Yue Cai; Andrew Page; Peng Yin; Yunning Liu; Yichong Li; Jiangmei Liu; Jinling You; Maigeng Zhou
Journal:  Bull World Health Organ       Date:  2015-10-28       Impact factor: 9.408

10.  Tackling the challenges to health equity in China.

Authors:  Shenglan Tang; Qingyue Meng; Lincoln Chen; Henk Bekedam; Tim Evans; Margaret Whitehead
Journal:  Lancet       Date:  2008-10-17       Impact factor: 79.321

View more
  567 in total

1.  Transplantation of neuregulin 4-overexpressing adipose-derived mesenchymal stem cells ameliorates insulin resistance by attenuating hepatic steatosis.

Authors:  Wenyue Wang; Yuxiang Zhang; Chengcan Yang; Yanni Wang; Jiahui Shen; Meilong Shi; Bing Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-01

2.  Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.

Authors:  Jia-Xin Huang; Yun-Fei Liao; Yu-Ming Li
Journal:  Curr Med Sci       Date:  2019-10-14

3.  The pleiotropic effect of rs7903146 on type 2 diabetes and ischemic stroke: a family-based study in a Chinese population.

Authors:  Jing Song; Yiqun Wu; Juan Juan; Yaying Cao; Tao Wu; Yonghua Hu
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

4.  [Effects of glycosylated hemoglobin and disease course on islet β-cell function in patients with type 2 diabetes].

Authors:  H E Yinhui; X U Haiyan; F U Qi; Yang Tao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-09-30

5.  Birthweight and early-onset type 2 diabetes in American Indians: differential effects in adolescents and young adults and additive effects of genotype, BMI and maternal diabetes.

Authors:  Muideen T Olaiya; Lauren E Wedekind; Robert L Hanson; Madhumita Sinha; Sayuko Kobes; Robert G Nelson; Leslie J Baier; William C Knowler
Journal:  Diabetologia       Date:  2019-05-20       Impact factor: 10.122

6.  Diabetes aggravates acute pancreatitis possibly via activation of NLRP3 inflammasome in db/db mice.

Authors:  Lin Gao; Guo-Tao Lu; Ying-Ying Lu; Wei-Ming Xiao; Wen-Jian Mao; Zhi-Hui Tong; Na Yang; Bai-Qiang Li; Qi Yang; Yan-Bing Ding; Wei-Qin Li
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

7.  Baicalin and its aglycone: a novel approach for treatment of metabolic disorders.

Authors:  Penghua Fang; Mei Yu; Mingyi Shi; Ping Bo; Xuewen Gu; Zhenwen Zhang
Journal:  Pharmacol Rep       Date:  2020-01-08       Impact factor: 3.024

8.  The intentions to get vaccinated against influenza and actual vaccine uptake among diabetic patients in Ningbo, China: identifying motivators and barriers.

Authors:  Lixia Ye; Ting Fang; Jun Cui; Guanghui Zhu; Rui Ma; Yexiang Sun; Pingping Li; Hui Li; Hongjun Dong; Guozhang Xu
Journal:  Hum Vaccin Immunother       Date:  2020-05-27       Impact factor: 3.452

9.  Influencing factors for peripheral and posterior lesions in mild non-proliferative diabetic retinopathy-the Kailuan Eye Study.

Authors:  Mo-Chi Yang; Xiao-Bo Zhu; Ya-Xing Wang; Shou-Ling Wu; Qian Wang; Yan-Ni Yan; Xuan Yang; Jing-Yan Yang; Meng-Xi Chen; Ya-Hui Lei; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

10.  Long-term effects of pattern scan laser pan-retinal photocoagulation on diabetic retinopathy in Chinese patients: a retrospective study.

Authors:  Chuang-Xin Huang; Kun-Bei Lai; Li-Jun Zhou; Zhen Tian; Xiao-Jing Zhong; Fa-Bao Xu; Ya-Jun Gong; Lin Lu; Chen-Jin Jin
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.